Financials in USD. Standardized financial statements.
A compact view of how Hemagen Diagnostics, Inc. turns revenue into operating income and net income.
| Metric | FY 2012 | FY 2011 | FY 2010 | FY 2009 | FY 2008 | FY 2007 | FY 2006 | FY 2005 | FY 2004 | FY 2003 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $4.04M | $5.14M | $5.22M | $5.42M | $6.37M | $4.49M | $4.78M | $7.59M | $7.47M | $8.47M |
| Revenue Growth? | -21.4% | -1.5% | -3.7% | -15.0% | +42.1% | -6.0% | -37.0% | +1.5% | -11.8% | 0.0% |
| Cost of Revenue? | $2.43M | $3.18M | $2.86M | $3.35M | $3.60M | $2.61M | $2.87M | $5.68M | $5.32M | $5.48M |
| Gross Profit? | $1.61M | $1.96M | $2.36M | $2.07M | $2.77M | $1.88M | $1.90M | $1.91M | $2.15M | $2.99M |
| Gross Margin? | +39.9% | +38.1% | +45.1% | +38.2% | +43.5% | +41.9% | +39.9% | +25.2% | +28.7% | +35.3% |
| Operating Expenses? | $2.05M | $2.43M | $2.12M | $2.42M | $2.65M | $2.04M | $2.07M | $2.78M | $2.72M | $2.75M |
| Operating Income? | -$437,914 | -$472,717 | $235,946 | -$348,714 | $118,034 | -$158,840 | -$165,112 | -$875,150 | -$569,048 | $244,519 |
| EBITDA? | -$273,894 | -$283,963 | $429,469 | -$191,978 | $225,586 | -$57,114 | -$65,415 | -$359,278 | $1.66M | $1.89M |
| Income Before Tax | -$907,315 | -$876,345 | -$66,735 | -$709,128 | -$244,028 | -$264,293 | $291,912 | -$1.29M | -$3.58M | $0 |
| Income Tax Expense | $0 | $4,131 | $89,579 | $20,821 | $129,333 | $47,515 | $75,461 | $49,137 | $23,738 | $0 |
| Net Income? | -$907,315 | -$880,476 | -$156,314 | -$808,148 | $427,163 | -$849,931 | $312,926 | -$1.34M | -$3.60M | -$1.27M |
| EPS? | $-0.06 | $-0.06 | $-0.01 | $-0.05 | $0.03 | $-0.06 | $0.02 | $-0.09 | $-0.36 | $-0.13 |
| Diluted EPS? | $-0.06 | $-0.06 | $-0.01 | $-0.05 | $0.03 | $-0.06 | $0.02 | $-0.09 | $-0.36 | $-0.13 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality